Dan G. Duda
Massachusetts General Hospital(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Angiogenesis and VEGF in Cancer, Cancer Immunotherapy and Biomarkers, Cancer, Hypoxia, and Metabolism, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer(2004)1,946 cited
- → Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges(2018)1,882 cited
- → AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients(2007)1,760 cited
- → Normalization of the Vasculature for Treatment of Cancer and Other Diseases(2011)1,541 cited
- → Angiogenesis in brain tumours(2007)1,377 cited
- → NASH limits anti-tumour surveillance in immunotherapy-treated HCC(2021)1,186 cited
- → Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy(2012)1,063 cited
- → Lessons from phase III clinical trials on anti-VEGF therapy for cancer(2006)1,035 cited
- → Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma(2017)957 cited
- → Engineering vascularized tissue(2005)804 cited